221050-88-0

基本信息
1-BOC-4-(2-氯嘧啶-4-基)哌嗪
2-氯-4-(4-BOC-1-哌嗪基)嘧啶
4-(2-氯嘧啶-4-基)哌嗪-1-甲酸叔丁酯
4-(2-氯嘧啶-4-基)哌嗪-1-羧酸叔丁基酯
2-Chloro-4-(4-Boc-1-piperazinyl)pyriMidine
1-Boc-4-(2-chloropyrimidin-4-yl)piperazine
2-Chloro-4-[1-(4-tert-butoxycarbonyl)piperazinyl]pyrimidine
ert-butyl4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate
tert-Butyl 4-(2-Chloro-4-pyrimidinyl)-1-piperazinecarboxylate
tert-Butyl 4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate
4-(2-Chloropyrimidin-4-yl)piperazine-1-carboxylic acid tert-butyl ester
1-Piperazinecarboxylic acid, 4-(2-chloro-4-pyrimidinyl)-, 1,1-dimethylethyl ester
物理化學性質
制備方法

3934-20-1

57260-71-6

221050-88-0
以2,4-二氯嘧啶和N-BOC-哌嗪為原料合成2-氯-4-(4-BOC-1-哌嗪基)嘧啶的一般步驟:準確稱取2,4-二氯嘧啶(2.0 g,13.43 mmol),溶解于N,N-二甲基甲酰胺(DMF)(15 mL)中,隨后加入三乙胺(TEA)(2.72 g,26.85 mmol)和1-Boc哌嗪(2.75 g,14.77 mmol)。將反應混合物在室溫下攪拌過夜。反應完成后,通過薄層色譜(TLC)監(jiān)測確認反應終點。將反應混合物緩慢倒入200 mL冰水中,此時有大量白色固體析出。通過過濾收集白色固體,并用適當的溶劑洗滌,最后干燥,得到目標產物2-氯-4-(4-BOC-1-哌嗪基)嘧啶(3.8 g,13.43 mmol)。
參考文獻:
[1] Patent: CN108503645, 2018, A. Location in patent: Paragraph 0117-0119
[2] Patent: US2009/163508, 2009, A1. Location in patent: Page/Page column 14
[3] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 4, p. 1468 - 1478
[4] Organic Letters, 2018, vol. 20, # 2, p. 473 - 476
[5] Patent: WO2017/58503, 2017, A1. Location in patent: Page/Page column 419; 421; 422